𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transfection of the type I TGF-β receptor restores TGF-β responsiveness in pancreatic cancer

✍ Scribed by Markus Wagner; Jörg Kleeff; Martha E. Lopez; Irene Bockman; Joan Massaqué; Murray Korc

Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
113 KB
Volume
78
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Transforming growth factor-beta (TGF-beta) signaling is initiated following heterodimerization of the type II TGF-beta receptor (TbetaRII) with the type I TGF-beta receptor (TbetaRI). Both receptors are required for TGF-beta responsiveness. In the present study, we characterized the actions of TGF-beta1 in T3M4 human pancreatic cancer cells, which express low levels of TbetaRI and high levels of TbetaRII. Cells were transiently transfected with p3TP-Lux, a TGF-beta-responsive luciferase reporter gene construct. TGF-beta1 was without effect in parental T3M4 cells, but caused a time- and dose-dependent increase in luciferase activity in T3M4 cells co-transfected with a TbetaRI cDNA expression vector. Co-transfection of TbetaRI with a truncated Smad4 cDNA that is known to block TGF-beta-dependent signaling, abrogated the TbetaRI-induced increase in luciferase activity. Sequencing of the TbetaRI and the Smad4 genes in T3M4 cells did not reveal any mutations. These findings indicate that one mechanism for TGF-beta resistance in pancreatic cancer is due to a quantitative decrease in TbetaRI expression.

📜 SIMILAR VOLUMES

Down-regulation of protein and mRNA expr
Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi

Restored expression of transforming grow
Restored expression of transforming growth factor β type II receptor in k-ras-transformed thyroid cells, TGFβ-resistant, reverts their malignant phenotype
✍ Anna Coppa; Gabriella Mincione; Davide Lazzereschi; Annalisa Ranieri; Alessandra 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 1 views

Transforming growth factor b1 (TGFb1) inhibits the growth of normal rat epithelial thyroid cells (FRTL-5 strain) by counteracting thyrotropin (TSH)-stimulated DNA synthesis and by slowing the cells in the G1 phase of the cell cycle. Here, we have studied two clones of FRTL-5 thyroid cell line transf

TGF-β-1 up-regulates cyclin D1 expressio
TGF-β-1 up-regulates cyclin D1 expression in colo-357 cells, whereas suppression of cyclin d1 levels is associated with down-regulation of the type I TGF-β receptor
✍ Marko Kornmann; Pam Tangvoranuntakul; Murray Korc 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB

Transforming growth factor-␤1 (TGF-␤1) inhibits cell growth in susceptible cells by interacting with a family of protein kinases that control cell cycle progression. In the present study, we investigated the effects of TGF-␤1 on cyclin D1 expression and activity in COLO-357 human pancreatic cancer c

CBFa(AML/PEBP2)-related elements in the
CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation
✍ Changhua Ji; Sandra Casinghino; David J. Chang; Yun Chen; Amjad Javed; Yoshiaki 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Organization of the transforming growth factor-␤ (TGF-␤) type I receptor (TRI) promoter predicts constitutive transcription, although its activity increases with differentiation status in cultured osteoblasts. Several sequences in the rat TRI promoter comprise cis-acting elements for CBFa (AML/PEBP2